Steady-state concentrations of mRNA encoding two inhibitors of protein kinase C in ovine luteal tissue

in Reproduction
Authors:
J. L. Juengel
Search for other papers by J. L. Juengel in
Current site
Google Scholar
PubMed Close
,
M. H. Melner
Search for other papers by M. H. Melner in
Current site
Google Scholar
PubMed Close
,
J. A. Clapper
Search for other papers by J. A. Clapper in
Current site
Google Scholar
PubMed Close
,
A. M. Turzillo
Search for other papers by A. M. Turzillo in
Current site
Google Scholar
PubMed Close
,
G. E. Moss
Search for other papers by G. E. Moss in
Current site
Google Scholar
PubMed Close
,
T. M. Nett
Search for other papers by T. M. Nett in
Current site
Google Scholar
PubMed Close
, and
G. D. Niswender
Search for other papers by G. D. Niswender in
Current site
Google Scholar
PubMed Close
DOI:
https://doi.org/10.1530/jrf.0.1130299
Volume/Issue:
Volume 113: Issue 2
Page Range:
299–305
Article Type:
Research Article
Online Publication Date:
Jul 1998
Free access

Sign up for journal news

Prostaglandin F2α (PGF2α) decreases secretion of progesterone from the corpus luteum in domestic ruminants. However, it is less effective during the early part of the oestrous cycle (Louis et al., 1973) and at the time of maternal recognition of pregnancy (Silvia and Niswender, 1984; Lacroix and Kann, 1986). Decreased luteal responsiveness may be due to failure of PGF2α to activate fully its normal second messenger system, protein kinase C (PKC). Alternatively, increased resistance of the corpus luteum to PGF2α might be attributable to greater concentrations of recently identified biological inhibitors of PKC. These possibilities were addressed by measuring steady-state concentrations of mRNA encoding PGF2α receptor and two inhibitors of PKC, protein kinase C inhibitor-1 (PKCI-1) and kinase C inhibitor protein-1 (KCIP-1, brain 14-3-3 protein), in corpora lutea collected from ewes on days 4, 10 and 15 of the oestrous cycle (n = 5 per day) and day 15 of pregnancy (n = 7). There were no differences in mean concentrations of mRNA encoding PGF2α receptor among the groups. However, concentrations of mRNA encoding both inhibitors of PKC were higher (P < 0.01) on day 4 of the oestrous cycle compared with the other groups. Treatment of ewes with a luteolytic dose of PGF2α, which activates PKC, did not change concentrations of mRNA encoding either PKCI-1 or KCIP-I up to 24 h later. Luteal expression of mRNA encoding the PKC inhibitors and PGF2α receptor was also examined in ewes treated with oestradiol in vivo for 16 h in the midluteal phase. High concentrations of oestradiol in serum (20 and 70 pg ml−1) did not influence quantities of any of the mRNAs examined. Therefore, an increase in PKC inhibitors may be involved in resistance of the corpus luteum to PGF2α during the early part of the oestrous cycle but does not appear to mediate the increased resistance of the corpus luteum to PGF2α during maternal recognition of pregnancy. Neither PGF2α nor oestradiol affected steady-state concentrations of mRNAs encoding PKCI-1 or KCIP-I.

Reproduction is committed to supporting researchers in demonstrating the impact of their articles published in the journal.

The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.

More information is on the Reasons to publish page.

Sept 2018 onwards Past Year Past 30 Days
Full Text Views 283 153 40
PDF Downloads 102 39 2

 

  • Collapse
  • Expand
Print ISSN:
1470-1626
Online ISSN:
1741-7899